IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9302991 B1

PDFFull Text
Date of Patent:
Apr. 05, 2016

Filed:

Oct. 18, 2011

Arylamide derivatives as ttx-s blockers

Applicants:

Tatsuya Yamagishi, Aichi, JP;

Kiyoshi Kawamura, Aichi, JP;

Yoshimasa Arano, Aichi, JP;

Mikio Morita, Aichi, JP;

Inventors:

Tatsuya Yamagishi, Aichi, JP;

Kiyoshi Kawamura, Aichi, JP;

Yoshimasa Arano, Aichi, JP;

Mikio Morita, Aichi, JP;

Assignee:

RaQualia Pharma Inc., Aichi, JP;

Attorney:

Wenderoth, Lind & Ponack, L.L.P.

Primary Examiner:

Alexander R Pagano

Int. Cl.
CPC ...
C07D 213/64 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); C07D 213/75 (2006.01); C07D 213/81 (2006.01); C07D 239/42 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 213/64 (2013.01); A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4427 (2013.01); A61K 31/506 (2013.01); C07D 213/75 (2013.01); C07D 213/81 (2013.01); C07D 239/42 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract

The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

Find Patent Forward Citations

Loading…